REVERAGEN BIOPHARMA, INC.
Home - ReveraGen BioPharma
Vienna, United States · Founded 2015
- Headquarters
- Vienna, Virginia
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- reveragen.com
About
ReveraGen BioPharma is a clinical-stage drug development company focused on therapeutics for neuromuscular and inflammatory diseases. Its flagship product vamorolone (brand name AGAMREE), a dissociative steroid with a corticosteroid-like mechanism but improved safety profile, received FDA and EMA approval in 2023 for treating Duchenne muscular dystrophy. ReveraGen operates under a venture philanthropy model, returning a majority of revenues to non-profit muscular dystrophy foundations.
Summary
REVERAGEN BIOPHARMA, INC. is a Biotech company based in Vienna, United States, founded in 2015.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/reveragen-biopharma-inc"><img src="https://indexed.vc/api/badge/company/reveragen-biopharma-inc" alt="REVERAGEN BIOPHARMA, INC. on Indexed.vc" width="260" height="76" /></a>